At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 4:10:19 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | -0.35 | 0 | -1.5 | -0.89 |
| Low Estimate | -0.36 | 0 | -1.57 | -0.94 |
| High Estimate | -0.34 | 0 | -1.43 | -0.84 |
| Year Ago EPS | -0.47 | -- | -1.83 | -1.5 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 4 |
| Avg. Estimate | 790k | 400k | 8.48M | 3.41M |
| Low Estimate | 500k | 400k | 8.2M | -- |
| High Estimate | 943k | 400k | 8.63M | 8.85M |
| Year Ago Sales | 2.09M | 5.27M | 7.88M | 8.48M |
| Sales Growth (year/est) | -62.18% | -92.42% | 7.71% | -59.83% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.51 | -0.59 | -0.4 |
| EPS Actual | -0.47 | -0.28 | -0.56 | -0.4 |
| Difference | 0.04 | 0.23 | 0.03 | -0.01 |
| Surprise % | 6.93% | 45.37% | 4.55% | -1.27% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.35 | 0 | -1.5 | -0.89 |
| 7 Days Ago | -0.32 | 0 | -1.5 | -0.89 |
| 30 Days Ago | -0.32 | 0 | -1.5 | -0.89 |
| 60 Days Ago | -0.32 | 0 | -1.5 | -0.87 |
| 90 Days Ago | -0.32 | 0 | -1.5 | -0.87 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | 2 | -- | 1 | 1 |
| Down Last 30 Days | 2 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BOLT | 25.53% | -- | 18.03% | 40.67% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 8/15/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 5/15/2024 |
| Downgrade | Jones Trading: Buy to Hold | 5/15/2024 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/15/2024 |
| Downgrade | Guggenheim: Buy to Neutral | 5/15/2024 |
Related Tickers
HLVX HilleVax, Inc.
1.8600
+1.64%
ASMB Assembly Biosciences, Inc.
15.21
-3.80%
NXTC NextCure, Inc.
0.9700
+2.11%
EPIX ESSA Pharma Inc.
1.6000
0.00%
IKNA Ikena Oncology, Inc.
1.5500
-3.73%
IPSC Century Therapeutics, Inc.
1.1000
+4.76%
CTMX CytomX Therapeutics, Inc.
1.0900
-0.91%
GLTO Galecto, Inc.
4.7000
+0.43%
PMVP PMV Pharmaceuticals, Inc.
1.5000
0.00%
ANTX AN2 Therapeutics, Inc.
1.2600
-0.79%